Companion Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

A companion diagnostic is a medical device and provides information that is necessary for the safe and effective use of a corresponding drug or biological product. The diagnostic test helps a health care professional to determine whether a particular therapeutic product is beneficial to patients and can outweigh any potentially severe side effects or risks.

MARKET DYNAMICS

The companion diagnostics market is expected to experience significant growth during the forecast period owing to surge in R&D of targeted therapies, rise in demand for personalized medicine with increase in awareness in emerging economies. Moreover, higher number of unmet needs for the treatment of cancer are majorly driving the growth of the global companion diagnostics market.

MARKET SCOPE

The "Companion Diagnostics Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of companion diagnostics market with detailed market segmentation by technology type and indication. The companion diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in companion diagnostics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The companion diagnostics market is segmented on the basis of technology type and indication. Based on technology type the market is segmented as immunohistochemistry, polymerase chain reaction [PCR], next generation sequencing [NGS], in situ hybridization, and others. On the basis of indication, the market is categorized as oncology, neurology, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the companion diagnostics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The companion diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting companion diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the companion diagnostics market in these regions.

Companion Diagnostics Market Report Analysis

Companion Diagnostics Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Abbott Laboratories Molecular, Inc.
• Agilent (Dako Denmark A/S)
• ARUP Laboratories
• BioMerieux SA
• Danaher Corporation (Leica Microsystems)
• Foundation Medicine, Inc.
• Myriad Genetics, Inc.
• Qiagen N.V.
• Roche (Ventana Medical Systems, Inc.)

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Technology Type

• Immunohistochemistry
• Polymerase Chain Reaction
• Next Generation Sequencing
• In Situ Hybridization

By Indication

• Oncology
• Neurology

MARKET PLAYERS

The report covers key developments in the companion diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from companion diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for companion diagnostics in the global market. Below mentioned is the list of few companies engaged in the companion diagnostics market.

The report also includes the profiles of key players in companion diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Abbott Laboratories Molecular, Inc.
  
•   Agilent (Dako Denmark A/S)
  
•   ARUP Laboratories
  
•   BioMerieux SA
  
•   Danaher Corporation (Leica Microsystems)
  
•   Foundation Medicine, Inc.
  
•   Myriad Genetics, Inc.
  
•   Qiagen N.V.
  
•   Roche (Ventana Medical Systems, Inc.)
  
•   Thermo Fisher Scientific (Life Technologies Corporation)
  
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Companion Diagnostics Market Report Scope